MedPath

蓬莱诺康药业有限公司

Ownership
-
Established
2002-06-07
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

81

NMPA:81

Drug Approvals

Thioctic Acid Injection

Product Name
硫辛酸注射液
Approval Number
国药准字H20243611
Approval Date
Apr 24, 2024
NMPA

Terlipressin for Injection

Product Name
注射用特利加压素
Approval Number
国药准字H20233916
Approval Date
Dec 18, 2023
NMPA

Rocuronium Bromide Injection

Product Name
罗库溴铵注射液
Approval Number
国药准字H20234197
Approval Date
Sep 28, 2023
NMPA

Thioctic Acid Capsule

Product Name
硫辛酸胶囊
Approval Number
国药准字H20133253
Approval Date
Apr 17, 2023
NMPA

Troxerutin Injection

Product Name
曲克芦丁注射液
Approval Number
国药准字H20045741
Approval Date
Apr 17, 2023
NMPA

Propylgallate Injection

Product Name
抚弘
Approval Number
国药准字H20051039
Approval Date
Apr 17, 2023
NMPA

Ozagrel Sodium for Injection

Product Name
注射用奥扎格雷钠
Approval Number
国药准字H20093081
Approval Date
Apr 17, 2023
NMPA

Propylgallate Injection

Product Name
抚弘
Approval Number
国药准字H20051040
Approval Date
Apr 17, 2023
NMPA

Sodium New Houttuyfonate for Injection

Product Name
兰宇
Approval Number
国药准字H20051336
Approval Date
Apr 17, 2023
NMPA

Tranexamic Acid Injection

Product Name
氨甲环酸注射液
Approval Number
国药准字H20233113
Approval Date
Jan 31, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.